GFR is a Key Determinant of Red Blood Cell Survival in Anemia Associated With Progressive CKD. Bissinger, Rosi (R);Schaefer, Lina (L);Bohnert, Bernhard N (BN);Schork, Anja (A);Hoerber, Sebastian (S);Peter, Andreas (A);Qadri, Syed M (SM);Birkenfeld, Andreas L (AL);Heyne, Nils (N);Bakchoul, Tamam (T);Wieder, Thomas (T);Artunc, Ferruh (F); |
Author information Kidney Int Rep.2024 Dec 21;10(3):730-742.doi:10.1016/j.ekir.2024.12.023 Abstract INTRODUCTION: Anemia is a common and clinically significant complication observed in patients with chronic kidney disease (CKD), resulting from complex interactions between renal dysfunction, erythropoietin (EPO) deficiency, and altered iron metabolism. In murine CKD models, red blood cell (RBC) death or eryptosis, characterized by exposure of phosphatidylserine (PS) on the outer membrane of RBCs, was observed to drive anemia. However, there is limited research that has investigated this phenomenon in patients with non-dialysis-dependent CKD (NDD-CKD). |
© Copyright 2013-2025 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.